Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002903.SZ
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 15.44 3.21 2.78
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 94.77 -4.20 -80.27
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.24 5.35 5.18
Cash -41.18 0.86 1.47
Capex 86.13 < 0.005 -0.03
Free Cash Flow -81.52 -0.25 1.36
Revenue -11.92 0.70 0.79
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -26.54 0.36 0.49
Operating Margin 48.28 0.11 0.08
ROA 505.52 0.01 < 0.005
ROE 474.26 0.01 < 0.005
ROIC -11.09 0.01 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002903.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002903.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002903.SZ is permitted for members.